6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Mimọ ≥99.0% Favipiravir Agbedemeji COVID-19
Olupese pẹlu Giga ti nw ati Idurosinsin Didara
Ipese Iṣowo Favipiravir ati Awọn agbedemeji ti o jọmọ:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Orukọ Kemikali | 6-Bromo-3-Hydroxypyrazine-2-Carboxamide |
Awọn itumọ ọrọ sisọ | Favipiravir Intermediate;Aimọ Favipiravir 4 |
Nọmba CAS | 259793-88-9 |
NỌMBA CAT | RF-PI296 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram |
Fọọmu Molecular | C5H4BrN3O2 |
Òṣuwọn Molikula | 218.01 |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Ina Yellow to Brown Powder |
Idanimọ | IR, HPLC |
Pipadanu lori Gbigbe | ≤1.0% |
Aloku lori Iginisonu | ≤0.20% |
Aimọ Kanṣoṣo | ≤0.50% |
Lapapọ Awọn Aimọ | ≤1.0% |
Awọn irin Heavy | ≤20ppm |
Awọn ohun elo ti o ku | Pade sipesifikesonu |
Igbeyewo Standard | Standard Enterprise |
Lilo | Agbedemeji ti Favipiravir (CAS 259793-96-9) |
Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.
6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) jẹ agbedemeji deede ni iṣelọpọ ti 6-Bromo-3-Hydroxypyrazine-2-Carboxamide ti a npè ni Favipiravir (CAS 259793-96-9) ni iṣowo. itọju ti awọn akoran ọlọjẹ aarun ayọkẹlẹ.Ọna ti o wulo ati igbese-aje si Favipiravir.Favipiravir jẹ ọja iwadii ti o ni ibatan COVID19, ni itọju awọn alaisan pẹlu COVID-19 ti WHO ṣeduro.Favipiravir, ti a tun mọ ni T-705 tabi Avigan, jẹ oogun ọlọjẹ ti o dagbasoke nipasẹ Toyama Chemical (Fujifilm Group) ti Japan pẹlu iṣẹ ṣiṣe lodi si ọpọlọpọ awọn ọlọjẹ RNA.Favipiravir ti fọwọsi fun tita ni Japan ni Oṣu Kẹta 2014 ati pe a lo fun itọju antiviral ti aarun ayọkẹlẹ A ati B. Ni afikun si ọlọjẹ aarun ayọkẹlẹ, oogun naa tun ṣe afihan iṣẹ-ṣiṣe antiviral ti o dara si ọpọlọpọ awọn ọlọjẹ RNA, gẹgẹbi ọlọjẹ Ebola, kokoro iyanrin, Kokoro Bunia, ọlọjẹ rabies, ati bẹbẹ lọ Ni Kínní 2020 Favipiravir ni a nṣe iwadi ni Ilu China fun itọju idanwo ti arun COVID-19 (Novel Coronavirus) pajawiri ati pe o ti ṣafihan awọn abajade rere.